Table 2.

Retinal hemorrhage at initial visit and median time to resolution

Location of Hemorrhage	Grade				Time to Resolution, months Median (25th-75th percentile)
	None	Mild	Moderate	Severe
Non-ischemic CRVO (n=490, 2 missing; except peripheral 5 missing, disc 3 missing)
Fovea (center)	255 (52%)	140 (29%)	61 (12%)	34 (7%)	8.5 (5.2–14.2)
Perifovea	123 (25%)	225 (46%)	108 (22%)	34 (7%)	9.3 (5.2–17.3)
Macular	71 (14%)	228 (47%)	151 (31%)	40 (8%)	9.4 (8.4–10.3)
Post. Pole	49 (10%)	240 (49%)	149 (31%)	52 (11%)	9.5 (6.2–17.6)
Peripheral	9 (2%)	334 (69%)	112 (23%)	32 (7%)	20.7 (8.5–40.9)
Disc	299 (61%)	122 (25%)	58 (12%)	10 (2%)	4.6 (3.4–6.3)
Peripapillary	143 (29%)	158 (32%)	109 (22%)	80 (16%)	6.8 (4.3–10.2)
Ischemic CRVO as first diagnosis (n=88, 1 missing; except post. pole 2 missing, disc 4 missing)
Fovea (center)	11 (13%)	21 (24%)	20 (23%)	35 (40%)	9.4 (6.2–17.7)
Perifovea	5 (6%)	15 (17%)	31 (35%)	37 (42%)	12.2 (8.6–33.6)
Macular	2 (2%)	14 (16%)	33 (38%)	39 (44%)	17.5 (10.5–40.0)
Post. Pole	3 (3%)	11 (13%)	34 (39%)	39 (45%)	18.9 (14.5–48.0)
Peripheral	1 (1%)	15 (17%)	36 (41%)	36 (41%)	34.4 (19.5–59.8)
Disc	47 (55%)	19 (22%)	11 (13%)	8 (9%)	4.8 (3.7–7.7)
Peripapillary	7 (8%)	12 (14%)	28 (32%)	41 (47%)	9.9 (7.2–14.4)
Ischemic CRVO converted from non-ischemic CRVO (n=46, 1 missing)
Fovea (center)	6 (13%)	7 (15%)	9 (20%)	24 (52%)	8.5 (6.2–13.4)
Perifovea	2 (4%)	4 (9%)	15 (33%)	25 (54%)	10.4 (7.9–14.7)
Macular	2 (4%)	1 (2%)	15 (33%)	28 (61%)	13.4 (9.5–21.7)
Post. Pole	1 (2%)	4 (9%)	15 (33%)	26 (57%)	14.7 (10.3–44.9)
Peripheral	1 (2%)	5 (11%)	21 (46%)	19 (41%)	38.7 (16.9–69.1)
Disc	24 (52%)	15 (33%)	3 (7%)	4 (9%)	3.3 (2.9–6.2)
Peripapillary	4 (9%)	6 (13%)	10 (22%)	26 (57%)	8.2 (5.7–13.4)